Summit Securities Group’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-192
Closed -$6.95K 1208
2025
Q1
$6.95K Buy
+192
New +$6.95K ﹤0.01% 450
2023
Q4
Sell
-657
Closed -$23K 659
2023
Q3
$23K Buy
+657
New +$23K ﹤0.01% 206
2014
Q4
Sell
-643
Closed -$36K 550
2014
Q3
$36K Buy
+643
New +$36K 0.01% 394
2014
Q2
Hold
0
538